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Background: Epitheloid leiomyoma is a rare subtype of benign smooth muscle tumors.
Results: Herein, we present the results of classical cytogenetics, MED12 mutation analysis, and copy number
variation array evaluation in one such case. Whereas cytogenetic did not show evidence for clonal chromosome
abnormalities and no MED12 mutation in the “fibroid hot spot” region was detected, array hybridization revealed
multiple abnormalities. Most noteworthy, almost all chromosomes showed copy-number neutral loss of heterozygosity.
As examples of further abnormalities, trisomies of chromosomes 8, 12, 20, and X were noted.
Discussion: The data presented suggest a near-haploid karyotype of the tumor as the initial genetic alteration followed
by secondary duplications of large parts of the genome. The absence of any clonal karyotypic alterations after performing
classical cytogenetics is likely explained by a reduced ability of the tumor cells to proliferate in vitro. However, to the best
of our knowledge this is the first report of an uterine leiomyoma showing extended uniparental disomy. It remains to be
determined if this is a more common phenomenon in epithelioid leiomyomas or even subsets of “ordinary” leiomyomas.
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Epithelioid leiomyoma is a rare variant of uterine leio-
myomas (UL) accounting for less than 1% of these tu-
mors. Nevertheless, clinical presentation as well as its
histology suggests a considerable degree of heterogeneity
among these lesions. Benign uterine smooth muscle tu-
mors neither carrying clonal cytogenetic deviations nor
mutations of the gene encoding mediator subcomplex
12 (MED12) [1], as predominantly found in cytogeneti-
cally normal UL [2], are rare. In an attempt to identify
genetic alterations in these lesions, we have analyzed an
epithelioid UL by copy number variation (CNV)-array in
addition to karyotyping and MED12 sequencing. By the
two latter methods the tumor did neither display clonal
karyotypic deviations nor a MED12 mutation akin to
those found in a large percentage of UL [1]. Besides* Correspondence: joern.bullerdiek@med.uni-rostock.de
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and some small gains and losses that had all escaped de-
tection by classical cytogenetics, the tumor showed uni-
parental disomy for most of the chromosomes except
for those affected by trisomies and tetrasomies. The pat-
tern of genetic alterations clearly distinguishes this lesion
from ordinary UL.Case presentation
A 45 year old patient was admitted to the hospital be-
cause of a large intramural uterine tumor which was
removed by hysterectomy. As a gross finding, a 7 cm
well-circumscribed tumor was found. Histologically, the
tumor presented as an encapsulated so-called epithelioid
leiomyoma (Figure 1) with mild nuclear atypica but no
enhanced mitotic activity or necrotic areas. There were
no signs of local invasiveness. Besides this single nodule
no further uterine tumors were detected. By classical cyto-
genetics, no clonal karyptypic abnormalities were detected
among a total of 20 metaphases fully analyzed (band reso-
lution: 300 -500bands per haploid set) (Figure 2) but onetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Histologic appearance of a so-called epithelioid
uterine smooth muscle tumor. Showing nests of cells displaying
an epithelial-like morphology embedded in a partly myxoid stroma.
(A). At a higher magnification part of the cells present with prominent
nuclei (B).
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karyotype.
In addition to cytogenetic examination, the tumor was
also analyzed for MED12 mutations by DNA-sequencing
as described earlier [1]. As a result, the tumor did not
display a MED12 mutation as commonly found in UL
(data not shown).
Finally, the tumor was investigated by whole genome
copy number variation (CNV)-arrays. Despite its appar-
ently normal karyotype in cell culture, this latter analysis
detected various genetic abnormalities. Most remarkably,
the tumor displayed large areas and even whole chromo-
somes with copy-number neutral loss of heterozygosity
(Figure 3).Figure 2 Representative G-banded karyotype. Displaying no numericalOf note, only chromosomes 8, 12, 20, and the X-
chromosome lacked this uniparental disomy but these
chromosomes showed copy number gains with three
(chromosome 12) or three to four copies (chromosomes 8,
20, and X) each. Chromosome 8 and the X-chromosome
presented with these copy number gains as well as with
large discontinuous stretches of uniparental disomy in a
few other chromosomes, small deletions were seen within
otherwise long chromosomal regions of homozygosity
(Table 1). Of these, one affecting a small segment on the
long arm of chromosome 7 (Figure 4) deserves particular
interest because it lies within the common region of overlap
of cytogenetically visible deletions of 7q. As the target gene
of these deletions CUX1 has been proposed earlier [3-5].
However, for none of the genetic alterations the evalu-
ation offered evidence for a significant proportion of
cells not carrying these alterations and its restriction to
a subset of the tumor cell population has been obtained.
Conclusions
In the case presented herein, array-based CNV detection
not only allowed to detect copy number variations but
also copy-number-neutral loss of heterozygosity (LOH)
or uniparental disomy, respectively. Apparently, most
chromosomes were in a disomic stated while they had
lost heterozygosity. The large extension of this copy-
number-neutral LOH [6] allows for the conclusion that
it has developed as a somatic alteration. As the most
likely explanation, the alterations detected have arisen
from a near-haploid tumor retaining e.g. both chromo-
somes 12 with secondary duplication of the chromosome
complement. The occurrence of near haploid karyotypes
has been observed in a variety of solid tumors includingor structural karyotype deviations.
Figure 3 Karyotype of the tumor visualized in Affymetrix Chromosome Analysis Suite v2.0.1 [ChAS] software. Long contiguous stretches
of homozygosity are (purple bars) observed in most chromosomes. The copy number state segments are shown in red (losses) or blue bars
(gains, light blue for copy number 3, dark blue for copy number 4).
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copy-number-neutral LOH affecting more or less large
segments has been observed in many cancers [9]. When
it affects larger parts of the genome, secondary duplica-
tions have been proposed as the underlying mechanism.
Duplication of the chromosomes as a later event has
e.g. been suggested to explain findings obtained by array
hybridization on chondrosarcomas. In a study of sixteen
chondrosarcomas that had been investigated by single
nucleotide polymorphism (SNP) arrays, the majority
of the tumors displayed SNP patterns indicative of a
hyperhaploid-hypodiploid origin, with or without subse-
quent polyploidization [10]. Despite chromosomal gains
detected by array analysis in the present case, no clonal
chromosome abnormalities were found by classical cyto-
genetics. The small deletion of 7q which was noted coin-
cides with a commonly deleted region in UL [3-5], but is
too small to be detected by classical cytogenetics. The
proximal border of the deleted segment lies in close prox-
imity of CUX1 but does not affect that gene. In contrast,
this proximal breakpoint is located within SH2B2. Never-
theless, the deletion may have removed downstream regu-
lating sequences of CUX1 thus not excluding CUX1 as a
possible target.
As to the molecular pathogenesis of the tumor, this
deletion as well as the gain of chromosome 12 are fre-
quent findings in other UL too and are likely to have
contributed to tumor development either as primary or
secondary alterations besides UPD.
In contrast, another explanation may account for the
lack of numerical chromosome alterations as clonal karyo-
type deviations. Recent findings of an in vitro selection
against tumor cells in some subtypes of fibroids [11] sug-
gest that this absence reflects an in vitro artefact.
In summary, to the best of our knowledge this is the
first report of an uterine leiomyoma showing extended
uniparental disomy. It remains to be determined if it is a
more common phenomenon in epithelioid leiomyomas
or even in subsets of ordinary leiomyomas.Methods
Histologic examination
The tumor was fixed in paraformaldehyde (4% in PBS)
and processed for paraffin embedding. Tissue sections
(1–2 μm thickness) were deparaffinized in xylene, rehy-
drated through a series of ethanol, and stained with
hematoxylin and eosin (H&E).
Cytogenetic studies
Chromosome analyses of cell cultures were performed
following routine techniques as described earlier [12].
DNA isolation
DNA from the frozen tissue sample was isolated using
the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany)
on a QIACube (Qiagen) according to the manufacturer’s
instructions.
PCR and sequencing
For PCR amplification 1000 ng of genomic template
DNA were used. Primers to amplify the desired human
PCR fragment of the MED12 gene were those recently
described [1,2]. Subsequently, PCR-products were sepa-
rated by agarose gel-electrophoresis and the desired DNA-
fragments/-bands were extracted by a QIAquick Gel
Extraction Kit (Qiagen) using a QIACube (Qiagen) ac-
cording to manufacturer’s instructions. DNA-sequencing
of the purified PCR-products was performed by GATC
Biotech (Konstanz, Germany).
Arrays
CNV (copy number variation) analysis was performed
using premade CytoScan HD Arrays (Affymetrix, Santa
Clara, CA) consisting of more than 2.4 million markers
for copy number and approximately 750,000 single nu-
cleotide polymorphisms (SNPs). Enriched gene coverage
for cancer and constitutional genes results in marker-
base ratio cover ages of 1/384 for ISCA, 1/553 for cancer
genes, 1/486 for X-chromosomal genes and 1/659 for
Table 1 Genetic abnormalities detected by whole genome CNV + SNP array hybridization
Chromosome Type CN Cytobands Size (kbp) Genes
1 UPD 2 All
Loss 1 q44 74.216 OR2T2, OR2T3, OR2T5
2 UPD 2 All
3 UPD 2 All
4 UPD 2 All
5 UPD 2 All
6 UPD 2 All
Loss 1 p22.1 71.464 HCG4B, HLA-A
Loss 1 q22.33 189.413 TMEM244, L3MBTL3
7 UPD 2 All




8 Gain 4 All
LOH 4 p12–p11.1 11659.74 71 genes
LOH 4 q23.3–q24.3 6392.362 14 genes
Loss 0 p11.22 139.855 ADAM5P, ADAM3A
9 UPD 2 All
10 UPD 2 All
11 UPD 2 All
12 Gain 3 All
13 UPD 2 All
14 UPD 2 All
Gain 3 q32.33 324.063 KIAA0125, ADAM6
15 UPD 2 All
Loss 1 q24.3 40.641 SCAPER
16 UPD 2 All
17 UPD 2 All
18 UPD 2 All
19 UPD 2 All
Loss 1 p12 677.28 ZNF682, ZNF90, ZNF486, MIR1270-2,
MIR1270-1, ZNF826P, ZNF737
Loss 1 q13.42 107.4 KIR2DL3, KIR2DL1, LOC100287534,
KIR2DL4, KIR3DL1, KIR2DS4
20 Gain 4 All
21 UPD 2 All
22 UPD 2 All
Gain 3 q11.22 138.446 MIR650, IGLL5
X Gain 4 All
LOH 4 p11.23–p11.1 8936.629 88 genes
LOH 4 q11.1–q13.1 5950.032 20 genes
LOH 4 q13.1–q21.1 5907.594 58 genes
LOH 2 q27.2–q27.3 1422261 3 genes
LOH 4 q27.3–q28 10557350 90 genes
Abbreviations: CN, Copy number.
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Figure 4 Detail view of chromosome 7. Copy number state segment (red bar for deletion) and copy number state data of a part of chromosomal
sub-band 7q22.1. Each dot represents the copy number state (weighted log2 ratio) of one marker. The right part of the figure shows the exon-intron-
structure of the genes in the displayed region. Numbering of positions is based on hg19 (NCBI Build 37 reference sequence).
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hybridization were done following the manufacturer’s
instructions. After staining and washing using a Gene-
Chip Fluidics Station 450 (Affymetrix) the arrays were
scanned by an Affymetrix 3000 7G scanner. Arrays were
analyzed through the Affymetrix Chromosome Analysis
Suite (ChAS) software (ChAS analysis files for CytoScan®
HD Array version NA32.3). Numbering of map positions
was based on hg19 (NCBI Build 37 reference sequence).
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